NovoDerma Inc. was born from a refusal to accept the status quo.
Following a routine dermatologic procedure, our founder was given the traditional post-operative protocol: a petrolatum-based ointment designed to simply "protect" the wound. Recognizing that passive protection is not the same as active healing, the founder went "off-script," applying a prototype regenerative cream powered by human growth factors.
The result was unexpected. The skin repaired itself so efficiently that a scheduled revision surgery was deemed unnecessary.
That moment defined our mission: to move skincare from passive protection to active regeneration.
What began as a quest for superior therapeutic healing evolved into a biotechnology platform capable of transforming how we approach aging, problem-specific cosmetic concerns, and professional clinical aftercare.